{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:22:41Z","timestamp":1782706961236,"version":"3.54.5"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neural Circuits"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is commonly characterized by severe dopamine (DA) depletion within the substantia nigra (SN) leading to a myriad of motor and non-motor symptoms. One underappreciated and prevalent non-motor symptom, Parkinson\u2019s disease-associated psychosis (PDAP), significantly erodes patient and caregiver quality of life yet remains vastly understudied. While the gold standard pharmacotherapy for motor symptoms Levodopa (LD) is initially highly effective, it can lead to motor fluctuations like LD-induced dyskinesia (LID) and non-motor fluctuations such as intermittent PDAP. One source of these fluctuations could be the serotonergic raphe nuclei and their projections. Serotonin (5-HT) neurons possess the machinery necessary to convert and release DA from exogenous LD. In DA-depleted brain regions these 5-HT projections can act as surrogates to the DA system initially compensating but chronically leading to aberrant neuroplasticity which has been linked to LID and may also contribute to non-motor fluctuations. In support, recent work from our lab established a positive relationship between LID and PDAP in parkinsonian rats. Therefore, it was hypothesized that normalizing 5-HT forebrain input would reduce the co-expression of LID and PDAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To do so, we expressed 5-HT projection specific inhibitory designer receptor exclusively activated by designer drugs (DREADDs) using Cre-dependent AAV9-hM4di in tryptophan hydroxylase 2 (TPH2)-Cre bilaterally 6-OHDA-lesioned rats. Thereafter we used the designer drug Compound 21 to selectively inhibit 5-HT raphe projections during LD treatment to modulate the expression of PDAP, assayed by prepulse inhibition (PPI) and LID, quantified by the abnormal involuntary movements (AIMs) test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results suggest that chemogenetic inhibition of 5-HT raphe-projecting cells significantly reduces LID without affecting stepping ability or established sensorimotor gating deficits<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Overall, this study provides further evidence for the complex influence of 5-HT raphe-projecting neurons on LD\u2019s neurobehavioral effects.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fncir.2024.1463941","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:24:30Z","timestamp":1732109070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Natalie","family":"Lipari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Galfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Grezenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette M.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/mds.10327","article-title":"Sensorimotor integration in movement disorders","volume":"18","author":"Abbruzzese","year":"2003","journal-title":"Mov. Disord."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/cells9102265","article-title":"The multimodal serotonergic agent vilazodone inhibits L-DOPA-induced gene regulation in striatal projection neurons and associated dyskinesia in an animal model of Parkinson\u2019s disease","volume":"9","author":"Altwal","year":"2020","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.3390\/molecules26195790","article-title":"Role of 5-HT1A receptor in vilazodone-mediated suppression of L-DOPA-induced dyskinesia and increased responsiveness to cortical input in striatal medium spiny neurons in an animal model of Parkinson\u2019s disease","volume":"26","author":"Altwal","year":"2021","journal-title":"Molecules"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00702-020-02247-2","article-title":"The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results","volume":"127","author":"Beaudry","year":"2020","journal-title":"J. Neural Transm. (Vienna, Austria:1996)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/WNF.0000000000000254","article-title":"Successful use of escitalopram for the treatment of visual hallucinations in patients with Parkinson disease","volume":"40","author":"Bergman","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/j.1460-9568.2012.08202.x","article-title":"Serotonin transporter inhibition attenuates l-DOPA induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats","volume":"36","author":"Bishop","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"91094","DOI":"10.1155\/2012\/591094","article-title":"Adenosine a(2A) receptor antagonists do not disrupt rodent Prepulse inhibition: an improved side effect profile in the treatment of Parkinson's disease","volume":"2012","author":"Bleickardt","year":"2012","journal-title":"Parkinsons Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1038\/s41467-019-12236-z","article-title":"High-potency ligands for DREADD imaging and activation in rodents and monkeys","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Nat. Commun."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/7854_2010_61","article-title":"Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia","volume":"4","author":"Braff","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1523\/JNEUROSCI.20-05-01952.2000","article-title":"Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity","volume":"20","author":"Brown","year":"2000","journal-title":"J. Neurosci."},{"key":"ref16","article-title":"Effects of Chemogenetic inhibition of serotonergic raphe-striatal neurons on circuit specificity and L-Dopa-induced behaviors in a rat model of Parkinson's disease","author":"Budrow","year":"2023"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells12060837","article-title":"Broad serotonergic actions of vortioxetine as a promising avenue for the treatment of L-DOPA-induced dyskinesia","volume":"12","author":"Budrow","year":"2023","journal-title":"Cells"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/awh088","article-title":"Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls","volume":"127","author":"Burton","year":"2004","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"20140184","DOI":"10.1098\/rstb.2014.0184","article-title":"Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?","volume":"370","author":"Calabresi","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/bph.14146","article-title":"The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats","volume":"175","author":"Campbell","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.870130108","article-title":"Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease","volume":"13","author":"Carter","year":"1998","journal-title":"Mov. Disord."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1523\/JNEUROSCI.10-06-01847.1990","article-title":"Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size","volume":"10","author":"Castaneda","year":"1990","journal-title":"J. Neurosci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fneur.2014.00242","article-title":"Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications","volume":"5","author":"Cenci","year":"2014","journal-title":"Front. Neurol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/mds.27959","article-title":"Dyskinesia Matters","volume":"35","author":"Cenci","year":"2020","journal-title":"Mov. Disord."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","article-title":"Psychosis in Parkinson's disease: epidemiology, pathophysiology, and management","volume":"76","author":"Chang","year":"2016","journal-title":"Drugs"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0079-6123(10)84017-8","article-title":"The challenge of non-motor symptoms in Parkinson\u2019s disease","volume":"184","author":"Chaudhuri","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"148381","DOI":"10.1016\/j.brainres.2023.148381","article-title":"Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats","volume":"1811","author":"Conti Mazza","year":"2023","journal-title":"Brain Res."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuropharm.2016.07.025","article-title":"Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats","volume":"110","author":"Conti","year":"2016","journal-title":"Int. J. Neuropharmacol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","article-title":"Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi- parkinsonian rats","volume":"77","author":"Conti","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tics.2007.10.011","article-title":"Serotoninergic regulation of emotional and behavioural control processes","volume":"12","author":"Cools","year":"2008","journal-title":"Cogn. Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2020.08.009","article-title":"The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques","volume":"78","author":"Depoortere","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0079-6123(08)00921-7","article-title":"Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson\u2019s disease and other motor disorders","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3","article-title":"Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model","volume":"15","author":"Di Monte","year":"2000","journal-title":"Mov. Disord."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/9781118892794.ch12","article-title":"The pathology of hallucinations: one or several points of processing breakdown?","volume-title":"The neuroscience of visual hallucinations","author":"Diederich","year":"2015"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mds.26460","article-title":"Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease","volume":"31","author":"Diederich","year":"2016","journal-title":"Mov. Disord."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.brainres.2007.05.005","article-title":"The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat","volume":"1158","author":"Dupre","year":"2007","journal-title":"Brain Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1353-8020(98)00012-1","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"4","author":"Ehringer","year":"1998","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0006-8993(91)90667-K","article-title":"Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats","volume":"552","author":"Engber","year":"1991","journal-title":"Brain Res."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.05.052","article-title":"L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson\u2019s disease","volume":"218","author":"Eskow Jaunarajs","year":"2012","journal-title":"Neuroscience"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2017.02.007","article-title":"Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: results of a levodopa challenge test","volume":"39","author":"Fabbri","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/ene.13376","article-title":"(2017). The role of neurotransmitters in the development of Parkinson's disease-related psychosis","volume":"24","author":"Factor","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF00422973","article-title":"The effects of l-Dopa, clonidine, and apomorphine on the acoustic startle reaction in rats","volume":"39","author":"Fechter","year":"1974","journal-title":"Psychopharmacologia"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson's disease","volume":"289","author":"F\u00e9nelon","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nmeth.2996","article-title":"Targeting cells with single vectors using multiple-feature Boolean logic","volume":"11","author":"Fenno","year":"2014","journal-title":"Nat. Methods"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"148613","DOI":"10.1016\/j.brainres.2023.148613","article-title":"Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion","volume":"1821","author":"Flores","year":"2023","journal-title":"Brain Res."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.22121","article-title":"Predictors and course of health-related quality of life in Parkinson's disease","volume":"23","author":"Forsaa","year":"2008","journal-title":"Mov. Disord."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"eabe5948","DOI":"10.1126\/sciadv.abe5948","article-title":"Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia","volume":"7","author":"Fridjonsdottir","year":"2021","journal-title":"Sci. Adv."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.nicl.2018.05.022","article-title":"Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB\/PET","volume":"19","author":"Fu","year":"2018","journal-title":"NeuroImage"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e87709","DOI":"10.1371\/journal.pone.0087709","article-title":"Distribution of VGLUT3 in highly collateralized axons from the rat dorsal raphe nucleus as revealed by single-neuron reconstructions","volume":"9","author":"Gagnon","year":"2014","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front. Neurol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1212\/WNL.43.11.2222","article-title":"Risk factors for nursing home placement in advanced Parkinson's disease","volume":"43","author":"Goetz","year":"1993","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e0238156","DOI":"10.1371\/journal.pone.0238156","article-title":"Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats","volume":"15","author":"Goutaudier","year":"2020","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00213-013-3320-5","article-title":"MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine a(2A) antagonist SCH 412348","volume":"231","author":"Grauer","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"113887","DOI":"10.1016\/j.bbr.2022.113887","article-title":"Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests","volume":"429","author":"Gubinelli","year":"","journal-title":"Behav. Brain Res."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.crneur.2022.100065","article-title":"Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats","volume":"4","author":"Gubinelli","year":"","journal-title":"Curr. Res. Neurobiol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric manifestation in patients with Parkinson's disease","volume":"33","author":"Han","year":"2018","journal-title":"J. Kor. Med. Sci."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicenter study of Parkinson\u2019s disease: non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/syn.890170102","article-title":"Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus","volume":"17","author":"Hensler","year":"1994","journal-title":"Synapse"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrn2866","article-title":"The habenula: from stress evasion to value-based decision-making","volume":"11","author":"Hikosaka","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1002\/gps.4736","article-title":"Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis","volume":"33","author":"Hinkle","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2217\/nmt.11.62","article-title":"Nondopaminergic treatments for Parkinson\u2019s disease","volume":"1","author":"Huot","year":"2011","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00221-013-3621-2","article-title":"The serotonergic system in motor and non-motor manifestations of Parkinson's disease","volume":"230","author":"Huot","year":"2013","journal-title":"Exp. Brain Res."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuropharm.2015.05.033","article-title":"The highly selective 5-HT<inf>1A<\/inf> agonist F15599 reduces l-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque","volume":"97","author":"Huot","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/mds.24964","article-title":"Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease","volume":"27","author":"Huot","year":"2012","journal-title":"Mov. Disord."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3940(00)01320-3","article-title":"Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striatum denervated with 6-hydroxydopamine","volume":"290","author":"Ishida","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lfs.2015.01.022","article-title":"Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease","volume":"125","author":"Issy","year":"2015","journal-title":"Life Sci."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","article-title":"Synuclein deposition and non-motor symptoms in Parkinson disease","volume":"310","author":"Jellinger","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/bs.irn.2017.05.005","article-title":"Neuropathology of nonmotor symptoms of Parkinson's disease","volume":"133","author":"Jellinger","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1038\/s41598-019-41088-2","article-title":"Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice","volume":"9","author":"Jendryka","year":"2019","journal-title":"Sci. Rep."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2006.03.059","article-title":"Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters","volume":"402","author":"Kannari","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/mds.28049","article-title":"Does urinary retention discriminate multiple system atrophy from Parkinson's disease?","volume":"35","author":"Kim","year":"2020","journal-title":"Mov. Disord."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1037\/0735-7044.109.5.912","article-title":"Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry","volume":"109","author":"Kodsi","year":"1995","journal-title":"Behav. Neurosci."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","article-title":"Prepulse inhibition in psychiatric disorders\u2013apart from schizophrenia","volume":"47","author":"Kohl","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1172\/JCI46229","article-title":"Rapid, reversible activation of AgRP neurons drives feeding behavior in mice","volume":"121","author":"Krashes","year":"2011","journal-title":"J. Clin. Invest."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"108465","DOI":"10.1016\/j.neuropharm.2021.108465","article-title":"Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease","volume":"186","author":"Kwan","year":"","journal-title":"Neuropharmacology"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00210-021-02090-6","article-title":"Further characterization of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset","volume":"394","author":"Kwan","year":"","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00702-017-1837-1","article-title":"Serotonergic targets for the treatment of L-DOPA-induced dyskinesia","volume":"125","author":"Lanza","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"113534","DOI":"10.1016\/j.expneurol.2020.113534","article-title":"Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia","volume":"336","author":"Lanza","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00213-015-3940-z","article-title":"Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats","volume":"232","author":"Larrauri","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.neubiorev.2007.01.004","article-title":"A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition","volume":"31","author":"Lecourtier","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2009.02.001","article-title":"Top\u2013down modulation of prepulse inhibition of the startle reflex in humans and rats","volume":"33","author":"Li","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1111\/bph.13937","article-title":"D-512, a novel dopamine D2\/3 receptor agonist, demonstrates greater anti-parkinsonian efficacy than ropinirole in parkinsonian rats","volume":"174","author":"Lindenbach","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/bph.12894","article-title":"Side effect profile of 5-HT treatments for Parkinson\u2019s disease and L-DOPA-induced dyskinesia in rats","volume":"172","author":"Lindenbach","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson\u2019s disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"105965","DOI":"10.1016\/j.nbd.2022.105965","article-title":"Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease","volume":"176","author":"Lipari","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41598-020-79110-7","article-title":"Cognitive impairment and levodopa induced dyskinesia in Parkinson\u2019s disease: a longitudinal study from the PACOS cohort","volume":"11","author":"Luca","year":"2021","journal-title":"Sci. Rep."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp. Neurol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S15250016(16)35398-9","article-title":"rAAV-mediated Nurr1 overexpression in striatal neurons results in enhanced levodopa induced Dyskinesias in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"22","author":"Manfredsson","year":"2014","journal-title":"Mol. Ther."},{"key":"ref97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/med\/9780199237234.003.0025","article-title":"Non-motor symptoms and health-related quality of life","volume-title":"Non-motor symptoms of Parkinson's disease","author":"Martinez-Martin","year":"2009"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/mds.100","article-title":"Diverse serotonin actions of vilazodone reduce l-3, 4-dihidroxyphenylalanine\u2013induced dyskinesia in hemi-parkinsonian rats","volume":"33","author":"Meadows","year":"2018","journal-title":"Mov. Disord."},{"key":"ref99","first-page":"880","article-title":"Half a century of L-DOPA","volume":"9","author":"Mena","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"ref100","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/978-3-030-88832-9_147","article-title":"Chemogenetics: DREADDs","volume-title":"Neuroscience in the 21st century: From basic to clinical","author":"Michaelides","year":"2022"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0306-4522(94)90008-6","article-title":"Behavioural recovery of rats grafted with dopamine cells after partial striatal dopaminergic depletion in a conditioned reaction-time task","volume":"63","author":"Moukhles","year":"1994","journal-title":"Neuroscience"},{"key":"ref102","article-title":"Guide for the care and use of laboratory animals","year":"2010"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s43440-022-00378-9","article-title":"Evaluation of the effects of the mGlu2\/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset","volume":"74","author":"Nuara","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00210-021-02162-7","article-title":"Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset","volume":"394","author":"Nuara","year":"2021","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00702-020-02196-w","article-title":"The mGlu2\/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmoset","volume":"127","author":"Nuara","year":"2020","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"2058460120988097","DOI":"10.1177\/2058460120988097","article-title":"Prefrontal and hippocampal atrophy using 7- tesla magnetic resonance imaging in patients with Parkinson's disease","volume":"10","author":"Oh","year":"2021","journal-title":"Acta Radiol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pneurobio.2015.09.005","article-title":"New insight into the therapeutic role of the serotonergic system in Parkinson's disease","volume":"134","author":"Ohno","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41531-021-00207-5","article-title":"Longitudinal evolution of non-motor symptoms in early Parkinson\u2019s disease: a 3-year prospective cohort study. Npj","volume":"7","author":"Ou","year":"2021","journal-title":"Parkinson's Dis."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001756-200403010-00035","article-title":"Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease","volume":"15","author":"Paill\u00e9","year":"2004","journal-title":"Neuroreport"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/mds.21308","article-title":"Rat model of Parkinson\u2019s disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias","volume":"22","author":"Paill\u00e9","year":"2007","journal-title":"Mov. Disord."},{"key":"ref113","first-page":"1","volume-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/mds.870100606","article-title":"Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus)","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov. Disord."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/nedt.2007.3.1.145","article-title":"Prodromal non-motor symptoms of Parkinson's disease","volume":"3","author":"Pellicano","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/ejn.14129","article-title":"Implementation of deep neural networks to count dopamine neurons in substantia nigra","volume":"48","author":"Penttinen","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/jnnp.2003.035022","article-title":"Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease","volume":"76","author":"Perriol","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/00325481.2019.1656515","article-title":"Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease","volume":"131","author":"Pezzoli","year":"2019","journal-title":"Postgrad. Med."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1172\/JCI71640","article-title":"Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients","volume":"124","author":"Politis","year":"2014","journal-title":"J. Clin. Invest."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","article-title":"Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study","volume":"40","author":"Politis","year":"","journal-title":"Neurobiol. Dis."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","article-title":"Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures","volume":"75","author":"Politis","year":"","journal-title":"Neurology"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/7854_2011_195","article-title":"Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders","volume":"12","author":"Powell","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nn.3779","article-title":"Reward processing by the lateral habenula in normal and depressive behaviors","volume":"17","author":"Proulx","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref125","first-page":"18","article-title":"Effect of levodopa and carbidopa on non-motor symptoms and signs of Parkinson's disease","volume":"23","author":"Rahman","year":"2014","journal-title":"Mymensingh Med. J."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/ana.22097","article-title":"Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia","volume":"68","author":"Rylander","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0006-8993(94)91533-4","article-title":"Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat","volume":"633","author":"Sakai","year":"1994","journal-title":"Brain Res."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-9065-8_6","article-title":"Multimodal production of adeno-associated virus","volume":"1937","author":"Sandoval","year":"2019","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/ene.14221","article-title":"Non\u2010motor symptom burden is strongly correlated to motor complications in patients with Parkinson\u2019s disease","volume":"27","author":"Santos-Garc\u00eda","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0091-3057(89)90372-9","article-title":"Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage","volume":"34","author":"Schneider","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/nmt-2017-0028","article-title":"Parkinson\u2019s disease psychosis: presentation, diagnosis and management","volume":"7","author":"Schneider","year":"2017","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/08919887211018280","article-title":"Psychosis in Parkinson's disease: current treatment options and impact on patients and caregivers","volume":"34","author":"Segal","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40478-018-0653-7","article-title":"Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia","volume":"7","author":"Sellnow","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00213-022-06078-9","article-title":"The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats","volume":"239","author":"Smith","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref135","first-page":"68","article-title":"Serotonin-immunoreactive neurons and their projections in the CNS","volume-title":"Classical transmitters and transmitter receptors in the CNS","author":"Steinbusch","year":"1984"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"11","author":"Swerdlow","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00008877-199809000-00002","article-title":"Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats","volume":"9","author":"Swerdlow","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"Neuroreport"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2005.11.026","article-title":"Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions","volume":"169","author":"Truong","year":"2006","journal-title":"Behav. Brain Res."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-201x.1971.tb11001.x","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e3446","DOI":"10.3791\/3446","article-title":"Habituation and Prepulse inhibition of acoustic startle in rodents","volume":"55","author":"Valsamis","year":"2011","journal-title":"J. Vis. Exp."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Res."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41386-022-01451-w","article-title":"Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity","volume":"48","author":"Vinogradov","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2011.07.008","article-title":"Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice","volume":"232","author":"Vuillermot","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1212\/WNL.54.7.1538","article-title":"Quetiapine forl-dopa\u2013induced psychosis in PD","volume":"54","author":"Weiner","year":"2000","journal-title":"Neurology"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00259-017-3844-8","article-title":"Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson\u2019s disease","volume":"45","author":"Yoo","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1212\/WNL.0000000000007189","article-title":"Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD","volume":"92","author":"Yoo","year":"2019","journal-title":"Neurology"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2165\/00002512-200825080-00004","article-title":"Pathophysiology and treatment of psychosis in Parkinson\u2019s disease","volume":"25","author":"Zahodne","year":"2008","journal-title":"Drugs Aging"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11940-010-0072-y","article-title":"Parkinson\u2019s psychosis","volume":"12","author":"Zahodne","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.parkreldis.2013.11.018","article-title":"Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson\u2019s disease and idiopathic REM sleep behavior disorder","volume":"20","author":"Zoetmulder","year":"2014","journal-title":"Parkinsonism Relat. Disord."}],"updated-by":[{"DOI":"10.3389\/fncir.2025.1593235","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["Frontiers in Neural Circuits"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncir.2024.1463941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T15:15:47Z","timestamp":1743520547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncir.2024.1463941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":153,"alternative-id":["10.3389\/fncir.2024.1463941"],"URL":"https:\/\/doi.org\/10.3389\/fncir.2024.1463941","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fncir.2025.1593235","asserted-by":"object"}]},"ISSN":["1662-5110"],"issn-type":[{"value":"1662-5110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"article-number":"1463941"}}